ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Septerna Inc

Septerna Inc (SEPN)

23.69
2.34
(10.96%)
Closed 05 January 8:00AM
23.60
-0.09
(-0.38%)
After Hours: 11:59AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
23.69
Bid
23.30
Offer
26.24
Volume
216,540
21.43 Day's Range 23.85
18.62 52 Week Range 28.99
Previous Close
21.35
Open
21.43
Last Trade
10
@
24.87
Last Trade Time
Average Volume (3m)
343,909
Financial Volume
US$ 5,021,405
VWAP
23.1893

SEPN Latest News

Septerna to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Septerna, a clinical-stage biotechnology company pioneering a new era of GPCR-targeted drug discovery, today announced that Jeffrey...

Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Deep Pipeline of GPCR Programs Focused Initially on Indications in Endocrinology, Immunology and Inflammation, and Metabolic Diseases Phase 1 Clinical Trial Ongoing for SEP-786, Oral Small...

Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR...

Septerna Prices Upsized Initial Public Offering

SOUTH SAN FRANCISCO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.86-7.2798434442325.5526.6920.6113908122.88553251CS
4-1.21-4.85943775124.928.9920.60950781023.88808467CS
120.190.80851063829823.528.9918.6234390923.47240701CS
260.190.80851063829823.528.9918.6234390923.47240701CS
520.190.80851063829823.528.9918.6234390923.47240701CS
1560.190.80851063829823.528.9918.6234390923.47240701CS
2600.190.80851063829823.528.9918.6234390923.47240701CS

SEPN - Frequently Asked Questions (FAQ)

What is the current Septerna share price?
The current share price of Septerna is US$ 23.69
What is the 1 year trading range for Septerna share price?
Septerna has traded in the range of US$ 18.62 to US$ 28.99 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
259.78M
NITON2OFF Inc
US$ 2.6306
(145.85%)
350.92M
CRNCCerence Inc
US$ 19.33
(143.76%)
159.55M
KITTNauticus Robotics Inc
US$ 3.8249
(140.56%)
104.78M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.59M
HWHHWH International Inc
US$ 0.4621
(-28.80%)
7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5.69
(-26.30%)
24.77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5.59
(-23.42%)
161.15k
PTLEPTL Ltd
US$ 9.35
(-23.30%)
1.04M
NXUNXU Inc
US$ 0.725868
(-22.78%)
7.59M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
TGLTreasure Global Inc
US$ 0.382
(101.58%)
337.5M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NVDANVIDIA Corporation
US$ 144.47
(4.45%)
230.01M

Discussion

View Full Feed
Kimbrown Kimbrown 2 minutes ago
Tim Pagliara: The GSE common is a long term hold following the exit from C-Ship. The returns will accelerate over time. You can hold higher concentrations of preferred with less execution risk than the common near term. Common will outperform long term after a successful exit from C-Ship.
FNMA
NoMoDo NoMoDo 3 minutes ago
I knew you weren't Shell, but I did think you might have had at least a relationship to the other one you mentioned if not the same person. Some bashers didn't know this and accused me of not knowing what a 10k was... LOL. They obviously will get docked some pay for making such a blunder.🤣
HMBL
dstock07734 dstock07734 4 minutes ago
Have you sorted out how much Merck would pay the upfront payment yet if Merck was the chosen one? Abandon all your old understanding about any biotech and think of NWBO as the company that can deliver the biggest revolution that you can dream about. Let me give you some sort of foundation so that yo
NWBO
Pittkid Pittkid 5 minutes ago
These stock are in TenKays avatar posting 
HMBL
Hardazoak Hardazoak 5 minutes ago
Beware of Basher spreading misinformation, Benny said they would multiple 10 X just before price is about to take off.
AABB
Investor082 Investor082 5 minutes ago
LOL. Yet you do not accept my bet!

There will be no financial support from big pharma. That is clear!
NWBO
TightCoil TightCoil 6 minutes ago
Shhhh
FNMA
doomed doomed 6 minutes ago
They are fucked big time. USA is about to place warnings on alcool bottles just as they did on tobacco. How will Simon spin that? Stay tuned.😂
TLRY
martyDg martyDg 6 minutes ago
Why would you sell long-term shares that you bought at a higher price for short-term shares with a lower cost? You'll have to wait a year for those short-term shares to convert to long-term before you can sell them, or else you'll face higher taxes on the sale. Anyway, there's no point in discussing
NWBO
Pittkid Pittkid 6 minutes ago
Sounds like TenKay....
HMBL
Phoenix64 Phoenix64 8 minutes ago
Nice assessment. In addition let’s get moving with PD, Schizophrenia and get Rett back in play while we are waiting for EMA. EMA approval along with Schizophrenia will be enough for 250 to 300 share price. Then add in PD and Rett. BP will fight hard to stop FDA from approving AVXL for AD. IMO
AVXL
skitahoe skitahoe 8 minutes ago
Dstock, I really have no idea if Merck's construction is in any way driven by DCVax-L, or not. It's clear that vaccines have to be made in cleanroom environments, but it's equally clear that the equipment needed to make millions of doses of a single vaccine is very different from the equipment need
NWBO
Jimmy Joe Jimmy Joe 8 minutes ago
if you have over $250,000 in the big banks, you better move some to other banks.

Not a very good idea to keep any money in a bank of any kind. Banks across the board, small, medium, and large are in dire straits.

All except maybe mom and pop banks are OVER LEVERAGED ma
AMC DJT
Kimbrown Kimbrown 8 minutes ago
😥Why Blackrock is the biggest beneficiary by holding FnF as hostage in conservatorship? Why Dems like Blackrock?
FNMA
PEACHMAN PEACHMAN 8 minutes ago
According to paid bashers the scientists and university Doctors do not exist and they are not testing IFUS products even though IFUS reported in several letters to shareholders that IFUS provided SGP+ and bagasse for testing.

Are you now slandering two universities and Oak Ridge labor
IFUS
12yearplan 12yearplan 9 minutes ago
Google got something right;.. these are good renditions of good songs, do enjoy 🫠:
[yt]7NTKeRzOq48[/yt]
WeTheMarket WeTheMarket 9 minutes ago
API Statement on Final Regulations for Section 45V Hydrogen Tax Credit
January 4, 2025
https://fuelcellsworks.com/2025/01/04/clean-energy/api-statement-on-final-regulations-for-section-45v-hydrogen-tax-credit

WASHINGTON— The American Petroleum Institute (API) released th
API
Toronto_Trader Toronto_Trader 9 minutes ago
No signs of front-loading.

Here is the chart from November 1 - December 30, 2024:

https://investorshub.advfn.com/uimage/uploads/2025/1/4/unkp[IMG_0160.png

Signs of front loading:
Large volume of shares traded within the course of several days or w
TWOH
Pittkid Pittkid 9 minutes ago
HMBL MULN VERB GME  are just a few mentioned in the article....practically the same stock in his avatar posting...
GME HMBL MULN
WeTheMarket WeTheMarket 9 minutes ago
API Statement on Final Regulations for Section 45V Hydrogen Tax Credit
January 4, 2025
https://fuelcellsworks.com/2025/01/04/clean-energy/api-statement-on-final-regulations-for-section-45v-hydrogen-tax-credit

WASHINGTON— The American Petroleum Institute (API) released th
API
Phantom Lord Phantom Lord 10 minutes ago
If they are cherry picking patients beyond just the listed enrollment criteria that would imply they have some method of screening patients to know who will respond to their therapy. If that is the case I would sure as sh*t hope they would say something about that.

As such I don't thi
MRKR
jimr1717 jimr1717 11 minutes ago
3 cents Friday.. It’s almost Two Cent Tuesday
IFUS
weedtrader420 weedtrader420 11 minutes ago
If you have $100,000 you can easily make $25,000 by the end of February
BTCUSD

Your Recent History

Delayed Upgrade Clock